In this study, we successfully knocked out the RSF1 gene using CRISPR/Cas9 technology in ESCC cell lines (KYSE450 and EC9706) and demonstrated its tumor-promoting function through both in vitro and in vivo experiments. This evidence concerns the gene RSF1 and neoplasm.